Are peptides steroids? What the legal categories actually say

Two different questions wearing one sentence

When someone asks whether peptides are steroids, they are usually asking two things at once, and the two have different answers from different authorities.

The first is a chemistry question. Are these the same kind of molecule? The second is the one that actually drives the worry: does buying this put me in the position that buying steroids would?

The chemistry question is settled and easy. The second question is not answered by the first, and treating it as though it were is where most of the confusion in this category comes from.

Federal law has a written definition of an anabolic steroid. Reading it answers the first question and shows exactly why it cannot answer the second.

What federal law defines an anabolic steroid to be

The definition sits in the drug scheduling regulations, and it is one sentence long.

An anabolic steroid means any drug or hormonal substance, chemically and pharmacologically related to testosterone, other than estrogens, progestins, corticosteroids and dehydroepiandrosterone. It then adds that the term includes, but is not limited to, the substances listed in the Schedule III regulation.

That is a test about the molecule. It asks what a substance is related to, chemically and pharmacologically, and it names testosterone as the reference point. A long list of named steroids follows in the schedule itself, and the list is explicitly not exhaustive.

The companion regulation places anabolic steroids in Schedule III of the Controlled Substances Act, which is where the legal consequences that people are actually worried about come from.

A peptide is a length, and it is not that reference point

A peptide is a short chain of amino acids. That describes a molecule's structure, and this site has a separate article on why that description says nothing about what a compound does or whether it is legal to sell.

The steroid definition is built around a different kind of molecule entirely. Testosterone and the substances related to it are steroids in the chemical sense, built on a fused ring structure rather than a chain of amino acids.

So the two categories are not neighbors that overlap at the edges. They are answers to different structural questions, which is why the definition reads the way it does.

What this does not tell you is anything about a particular product. Scheduling is decided substance by substance, and this article does not census which substances in this market are scheduled and which are not.

Where the answer for a specific product is printed

For any approved drug there is a place to look, and it is the same place every time.

An approved product that is a controlled substance says so in its own labeling, in a section headed Drug Abuse and Dependence. The approved testosterone cypionate injection states that it contains testosterone, a Schedule III controlled substance in the Controlled Substances Act.

That single line is the whole disclosure. It names the substance, names the schedule and names the statute, and it is printed in the labeling rather than left for a buyer to infer.

This site has an article on reading an approved label section by section. The relevant habit here is narrow: the scheduling statement lives in the labeling, so a claim about scheduling made anywhere else is a claim you can check.

Most of what is sold in this category has no approved labeling at all, which is a different problem and the subject of three other articles here.

Three axes, and a compound can sit badly on all of them

The reason the steroid question feels like it should settle things, and does not, is that it is one of three independent questions.

The first is whether a substance is a controlled substance. That is decided under the Controlled Substances Act and is what scheduling means.

The second is whether a product is approved. That is a separate regime, and the agency has stated plainly that compounded drugs are not approved and that it does not verify their safety, effectiveness or quality before they are marketed.

The third is whether a substance is prohibited in sport, which is decided by an anti-doping list rather than by either of the first two. Several compounds sold in this market are named on it, and that has its own article here.

A substance can be unscheduled, unapproved and prohibited in sport at the same time. Nothing about those three answers has to agree, because three different bodies are answering three different questions.

Why growth hormone compounds feel like the closest call

The compounds that draw this question hardest are the ones marketed for muscle, recovery and body composition, because those are the results steroids are known for.

Several of them work on the growth hormone axis. A releasing factor or a secretagogue prompts the pituitary rather than supplying a hormone directly, and this site has articles and comparisons on what that distinction does and does not buy you.

Sharing a marketing promise with anabolic steroids is not sharing a legal category with them. The definition quoted above turns on relation to testosterone, not on whether a compound is sold for the same outcome.

The reverse trap matters more. Falling outside the steroid definition does not place a compound inside any approved category, and for most of what is sold here it places it nowhere at all.

SARMs are a third thing, and the agency has been explicit

Selective androgen receptor modulators come up constantly in the same conversation, and they are neither peptides nor anabolic steroids as the regulation defines them.

The agency describes them as chemical substances that mimic the effects of testosterone and anabolic steroids, and says bodybuilding products containing them have not been approved.

It goes further on how they are sold. Although the products are generally marketed as dietary supplements, they are not dietary supplements, and are instead unapproved drugs that the agency has not reviewed for safety and effectiveness.

A second agency page notes that they are often marketed as dietary supplements or sold for research use only, and are considered unapproved drugs regardless. That second phrase is the same label this site examines in its own article on research-use-only vials.

The pattern is worth naming because it repeats across this whole market. A product wears the wording of a category it does not belong to, and the wording is doing the persuading.

What to do with the answer

Treat "it is not a steroid" as a statement about chemistry, because that is all the definition makes it.

Ask the approval question separately. Whether a compound has an approved product, is being used off-label, or has no approval at all is the axis that governs most of what is sold here, and it has its own article.

Ask the sport question separately again if you are tested, because the anti-doping answer does not follow from either of the other two.

For an approved product, read the labeling for a Drug Abuse and Dependence section. That is where a scheduling statement appears when there is one.

Be suspicious of any listing that answers the steroid question and then stops. The answer is real, and on its own it tells a buyer almost nothing about what they are being sold.

Anything about your own treatment, including whether any of this is appropriate for you, comes from your prescriber and the labeling supplied with your medication.

Sources

Each document below is named as it names itself, with the date printed on that document rather than the day it was read.

1. 21 CFR 1300.01, Definitions relating to controlled substances — Office of the Federal Register, Electronic Code of Federal Regulations, July 2026
2. 21 CFR 1308.13, Schedule III — Office of the Federal Register, Electronic Code of Federal Regulations, April 2026
3. DEPO-TESTOSTERONE (testosterone cypionate) injection — FDA-approved prescribing information — National Library of Medicine, DailyMed, August 2026
4. Bodybuilding Products: SARMs Cause Harm — U.S. Food and Drug Administration, December 2025
5. FDA Warns of Use of Selective Androgen Receptor Modulators (SARMs) Among Teens, Young Adults — U.S. Food and Drug Administration, April 2023
6. Compounding and the FDA: Questions and Answers — U.S. Food and Drug Administration, September 2025